220 results on '"Lüscher, Thomas F"'
Search Results
2. Medical Misinformation
3. Insufficient Medication Documentation at Hospital Admission of Cardiac Patients: A Challenge for Medication Reconciliation
4. Endothelial Nitric Oxide Synthase Gene Transfer Inhibits Human Smooth Muscle Cell Migration via Inhibition of Rho A
5. Effects of Tacrolimus or Sirolimus on Proliferation of Vascular Smooth Muscle and Endothelial Cells
6. Statins Blunt Thrombin-induced Down-regulation of Endothelial Nitric Oxide Synthase Expression in Human Endothelial Cells
7. Endogenous Estrogens Increase Postischemic Hyperemia in the Skin Microcirculation
8. Age-Related Changes of Vitamin A Status
9. Vascular Effects of Newer Cardiovascular Drugs: Focus on Nebivolol and ACE-Inhibitors
10. Current Strategies and Perspectives for Correcting Endothelial Dysfunction in Atherosclerosis
11. Introduction
12. Vascular Protective Effects of Angiotensin Converting Enzyme Inhibitors and their Relation to Clinical Events
13. Systemic, Pulmonary, and Renal Hemodynamic Effects of Endothelin ETA/B-Receptor Blockade in Patients with Maintained Left Ventricular Function
14. Nebivolol Induces NO-Mediated Relaxations of Rat Small Mesenteric But Not of Large Elastic Arteries
15. Nebivolol Inhibits Human Aortic Smooth Muscle Cell Growth: Effects on Cell Cycle Regulatory Proteins
16. Efficacy and Tolerability of Fluvastatin and Bezafibrate in Patients with Hyperlipidemia and Persistently High Triglyceride Levels
17. Tetrahydrobiopterin Improves Endothelial Function in Patients with Coronary Artery Disease
18. Endothelin in Atherosclerosis: Importance of Risk Factors and Therapeutic Implications
19. Introduction
20. Endothelin Regulates Angiotensin-Converting Enzyme in the Mouse Kidney
21. Inverse Regulation of Endothelin-1 and Nitric Oxide Metabolites in Tissue with Aging
22. Introduction
23. Angiotensin Converting Enzyme Inhibitors and Vascular Protection in Hypertension
24. Introduction
25. Platelet-Derived Growth Factor-Induced Vasodilatation in Mesenteric Resistance Arteries by Nitric Oxide: Blunted Response in Spontaneous Hypertension
26. Propofol-Induced Relaxation of Rat Mesenteric Arteries: Evidence for a Cyclic GMP-Mediated Mechanism
27. Endothelium-Independent Relaxation and Hyperpolarization to C-Type Natriuretic Peptide in Porcine Coronary Arteries
28. Differential Modulation of the Renal and Myocardial Endothelin System by Angiotensin II In Vivo
29. Combination of ACE Inhibitors and Calcium Antagonists: A Logical Approach
30. Development of Nitrate Tolerance in Human Arteries and Veins
31. Differential Effects of the Calcium Antagonist Mibefradil in Epicardial and Intramyocardial Coronary Arteries
32. Endothelial Dysfunction in Aorta of the Spontaneously Hypertensive, Stroke-Prone Rat
33. Angiotensin Blockade or Calcium Antagonists Improve Endothelial Dysfunction in Hypertension
34. Activity of the L-Arginine/Nitric Oxide Pathway and Endothelin-1 in Experimental Heart Failure
35. Endothelium Dysfunction in the Coronary Circulation
36. Acetylsalicylic Acid, at High Concentrations, Inhibits Vascular Smooth Muscle Cell Proliferation
37. Efficacy and Safety of Various Combination Therapies Based on a Calcium Antagonist in Essential Hypertension
38. Different Effects of Angiotensin-Converting Enzyme Inhibition in Human Arteries and Veins
39. Altered Intra- and Extraluminal Effects of 5-Hydroxytryptamine in Hypertensive Mesenteric Resistance Arteries
40. Different Potency of Endothelium-Derived Relaxing Factors Against Thromboxane, Endothelin, and Potassium Chloride in Intramyocardial Porcine Coronary Arteries
41. Calcium Antagonists as First-Line Therapy in Hypertension
42. Endothelin
43. Differential Effect of Cyclic GMP on the Release of Endothelin-1 from Cultured Endothelial Cells and Intact Porcine Aorta
44. Protection of Endothelial Function: Targets for Nutritional and Pharmacological Interventions.
45. Cyclooxygenase-2 Inhibition and Coagulation.
46. Different Mobilization of Calcium in Endothelin-1 -Induced Contractions in Human Arteries and Veins: Effects of Calcium Antagonists
47. Systemic, Pulmonary, and Renal Hemodynamic Effects of Endothelin ETA/B-Receptor Blockade in Patients with Maintained Left Ventricular Function.
48. Vascular Effects of Endothelin-1 in Essential Hypertension: Relationship with Cyclooxygenase-Derived Endothelium-Dependent Contracting Factors and Nitric Oxide.
49. Endothelin-Converting Enzyme Inhibitors: Current Status and Perspectives.
50. Endothelin Antagonists and Renal Protection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.